NEW TEAM AT KEMSA MUST BE FIRM TO UPROOT GRAFT FOLLOWING NEW REVELATIONS

 924 views

Kenya risks losing Kshs. 50.6 billion in support of health programmes control and treatment programmes following revelations of suspected graft at the Kenya Medical Supplies Agency (Kemsa) after an audit by the Global Fund.

The funds were spent on purchase of drugs meant for control and treatment of HIV/Aids, tuberculosis and malaria. The audit by Global Fund revealed that the medicine purchased through the programme is believed to have been stolen and resold on the black market and to private chemists.

The audit found that in the period from January 2018 to April 2021, a massive 908,000 mosquito nets, 1.1 million condoms and tuberculosis drugs worth Kshs.10 million disappeared from KEMSA’s warehouse.

Further, the fund also flagged out suspected fake suppliers demanding Kshs.1.66 billion from KEMSA.

Poor internal controls on warehousing and inventory management has been blamed on the woes facing the agency.
In May 2021, the government moved in to reform KEMSA by installing a new team. This latest revelation means the new team has to work harder to bring this key government agency back agency to its feet.

Leave a Reply

Your email address will not be published.